Apollon Formularies Plc - Result of General Meeting
28 May 2024 - 11:20PM
UK Regulatory
Apollon Formularies Plc - Result of
General Meeting
PR Newswire
LONDON, United Kingdom, May 28
28 May
2024
Apollon Formularies
Plc
Result of GM
Apollon Formularies plc (AQSE: APOL,
"Apollon" or
the "Company") announces that the withdrawal
resolution was duly passed at the Company's General Meeting held
today, 28 May 2024, and the Company's
ordinary shares will therefore be withdrawn from trading on the
Aquis Growth Market with effect from the close of business on
3 June
2024.
The directors of the Company accept responsibility
for the contents of this
announcement.
-ENDS-
For additional information, please
visit www.apollon.org.uk or
contact:
Apollon
Formularies
Tel:
+44 771 198
0221
Stene
Jacobs stene@apollon.org.uk
Peterhouse Capital Limited (Corporate Adviser)
Tel:
+44 20 7469
0930
Mark
Anwyl
Brefo Gyasi
About Apollon Formularies and Apollon Formularies
Jamaica
Apollon Formularies plc is an international medical
cannabis and medicinal mushroom pharmaceutical company. Apollon
Formularies Jamaica Limited is a pharmaceutical company
incorporated and operating in the Commonwealth of Jamaica since
2016. Apollon Jamaica is licensed by
the Jamaican government's Cannabis Licensing Authority (CLA) to
cultivate (R&D), perform research and development, process, and
sell medical cannabis therapeutic products that include legal
medical cannabis to treat various illnesses under medical
supervision.
Apollon Formularies (AQSE:APOL)
Historical Stock Chart
From May 2024 to Jun 2024
Apollon Formularies (AQSE:APOL)
Historical Stock Chart
From Jun 2023 to Jun 2024